Cigarette smoking is associated with an increased risk of biochemical disease recurrence, metastasis, castration-resistant prostate cancer, and mortality after radical prostatectomy: results from the SEARCH database

Authors

D. M. Moreira, Northwell Health
W. J. Aronson
M. K. Terris
C. J. Kane
C. L. Amling
M. R. Cooperberg
P. Boffetta
S. J. Freedland

Publication Date

2014

Journal Title

Cancer

Abstract

BACKGROUND: The current study was conducted to analyze the association between cigarette smoking and metastasis (the primary outcome) as well as time to biochemical disease recurrence (BCR), metastasis, castration-resistant prostate cancer (CRPC), and prostate cancer-specific and overall mortality (secondary outcomes) after radical prostatectomy among men from the Shared Equal Access Regional Cancer Hospital cohort. METHODS: A retrospective analysis was performed of 1450 subjects for whom smoking status was available from preoperative notes. Analysis of baseline characteristics by smoking status was performed using the chi-square and rank sum tests. The association between smoking status and time to the event was analyzed using Kaplan-Meier plots, the log-rank test, and Cox and competing risk models. RESULTS: A total of 549 men (33%) men were active smokers and 1121 (67%) were nonsmokers at the time of surgery. Current smokers were younger and had a lower body mass index, higher prostate-specific antigen level, and more extracapsular extension and seminal vesicle invasion (all P

Volume Number

120

Issue Number

2

Pages

197-204

Document Type

Article

EPub Date

2013/10/16

Status

Northwell Researcher

Facility

Northwell Health

Primary Department

Urology

PMID

24127391

DOI

10.1002/cncr.28423